Assessment of Functional Capacity, Pain, Cognitive and Respiratory Functions in Lung Cancer Survivors
NCT ID: NCT04431921
Last Updated: 2020-06-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
60 participants
OBSERVATIONAL
2017-07-17
2018-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Dual Task Performance and Respiratory Muscle Endurance in Patients With Lung Cancer
NCT06251570
Pulmonary and Extrapulmonary Impairments in Patients With Lung Cancer Awaiting Surgery
NCT04450719
Multidimensional Evaluation Of Daily Living Activities And Quality Of Life In Lung Cancer Patients
NCT03881046
Pulmonary Rehabılıtatıon Wıth Non-Small Lung Cancer
NCT05320458
Maximal Exercise Capacity and Extra-pulmonary Characteristics in Patients With Lung Cancer With Complete Remission .
NCT03838757
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Pulmonary function testing (PFT), mouth pressure measurement (MIP- maximal inspiratory pressure and MEP- maximal expiratory pressure), respiratory muscle endurance test, six minute walk test (6MWT) and pain threshold and tolerance test were used. In addition to physiological measurements, the Montreal Cognitive Assessment (MoCA) scale was used to evaluate cognitive status, the International Physical Activity Questionnaire (IPAQ) was used to determine the level of physical activity.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Lung cancer patients
Lung cancer survivors who had stable conditions and routine follow-up at Hacettepe University Oncology Hospital
Functional capacity
Six minute walk test used assessment of functional capacity. For respiratory function mouth pressures, for cognitive functions MoCA scale and for pain assessment pain threshold and tolerance test assessed.
Healthy subjects
No health problems related or affect outcome measure parameters examined in this study.
Functional capacity
Six minute walk test used assessment of functional capacity. For respiratory function mouth pressures, for cognitive functions MoCA scale and for pain assessment pain threshold and tolerance test assessed.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Functional capacity
Six minute walk test used assessment of functional capacity. For respiratory function mouth pressures, for cognitive functions MoCA scale and for pain assessment pain threshold and tolerance test assessed.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* lung cancer patients who had a stable condition
Exclusion Criteria
* Brain metastasis story
* Any orthopedic disease impairs walking, balance
45 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hacettepe University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kübra Kılıç
Physiotherapist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Naciye Vardar-Yagli, PhD
Role: STUDY_DIRECTOR
Hacettepe University
Deniz Inal-Ince, Professor
Role: STUDY_CHAIR
Hacettepe University
Melda Saglam, PhD
Role: STUDY_CHAIR
Hacettepe University
Ebru Calik-Kütükcü, PhD
Role: STUDY_CHAIR
Hacettepe University
Hulya Arikan, Professor
Role: STUDY_CHAIR
Hacettepe University
Saadettin Kilickap, Professor
Role: STUDY_CHAIR
Hacettepe University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hacettepe University
Ankara, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GO17/555
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.